Involvement of heme oxygenase-1 expression in neuroprotection by piceatannol, a natural analog and a metabolite of resveratrol, against glutamate-mediated oxidative injury in HT22 neuronal cells

Amino Acids

Volumn 45, Issue 2, 2013, Pages 393-401

  Son, Yong ^a   Byun, Seung Jae ^a   Pae, Hyun Ock ^a  

^a Wonkwang University   (South Korea)

Author keywords

Glutamate; Heme oxygenase 1; Neuronal cells; Piceatannol; Reactive oxygen species; Resveratrol

Indexed keywords

DRUG METABOLITE; GLUTAMIC ACID; HEME OXYGENASE 1; PICEATANNOL; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRANSCRIPTION FACTOR NRF2;

ARTICLE; CONCENTRATION (PARAMETERS); DOWN REGULATION; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRUCTURE ANALYSIS;

ANIMALS; CELL LINE; CELL SURVIVAL; CYTOPROTECTION; GLUTAMATES; HEME OXYGENASE-1; MEMBRANE PROTEINS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STILBENES;

EID: 84880832812     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-013-1518-9     Document Type: Article

References (35)

1. Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, Colombo L, Manzoni C, Salmona M, Caccia S, Negro A, Forloni G (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J Neurochem 110:1445-1456
2. Albani D, Polito L, Signorini A, Forloni G (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. BioFactors 36:370-376
3. Amri A, Chaumeil JC, Sfar S, Charrueau C (2012) Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 158:182-193
4. Bastianetto S, Dumont Y, Han Y, Quirion R (2009) Comparative neuroprotective properties of stilbene and catechin analogs: action via a plasma membrane receptor site? CNS Neurosci Ther 15:76-83
5. Billack B, Radkar V, Adiabouah C (2008) In vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs. Cell Mol Biol Lett 13:553-569
6. Chowdhury SA, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, Shirataki Y, Sakagami H (2005) Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res 25:2055-2063
7. Eghwrudjakpor PO, Allison AB (2010) Oxidative stress following traumatic brain injury: enhancement of endogenous antioxidant defense systems and the promise of improved outcome. Niger J Med 19:14-21
8. Esposito E, Cuzzocrea S (2010) New therapeutic strategy for Parkinson's and Alzheimer's disease. Curr Med Chem 17:2764-2774
9. Frombaum M, Therond P, Djelidi R, Beaudeux JL, Bonnefont-Rousselot D, Borderie D (2011) Piceatannol is more effective than resveratrol in restoring endothelial cell dimethylarginine dimethylaminohydrolase expression and activity after high-glucose oxidative stress. Free Radic Res 45:293-302
10. Fukui M, Choi HJ, Zhu BT (2010) Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic Biol Med 49:800-813
11. Jazwa A, Cuadrado A (2010) Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases. Curr Drug Targets 11:1517-1531
12. Jellinger KA (2009) Recent advances in our understanding of neurodegeneration. J Neural Transm 116:1111-1162
13. Jomova K, Vondrakova D, Lawson M, Valko M (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345:91-104
14. Kaplan S, Bisleri G, Morgan JA, Cheema FH, Oz MC (2005) Resveratrol, a natural red wine polyphenol, reduces ischemia-reperfusion-induced spinal cord injury. Ann Thorac Surg 80:2242-2249
15. Kelsey NA, Wilkins HM, Linseman DA (2010) Nutraceutical antioxidants as novel neuroprotective agents. Molecules 15:7792-7814
16. Kim HP, Pae HO, Back SH, Chung SW, Woo JM, Son Y, Chung HT (2011) Heme oxygenase-1 comes back to endoplasmic reticulum. Biochem Biophys Res Commun 404:1-5
17. Kim DW, Kim YM, Kang SD, Han YM, Pae HO (2012) Effects of resveratrol and trans-3,5,4'-trimethoxystilbene on glutamate-induced cytotoxicity, heme oxygenase-1, and sirtuin 1 in HT22 neuronal cells. Biomol Ther 20:306-312
18. Lee HH, Park SA, Almazari I, Kim EH, Na HK, Surh YJ (2010) Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling. Arch Biochem Biophys 501:142-150
19. Li F, Gong Q, Dong H, Shi J (2012) Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr Pharm Des 18:27-33
20. Marambaud P, Zhao H, Davies P (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 280:37377-37382
21. Morimoto BH, Koshland DE Jr (1990) Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line. Neuron 5:875-880
22. Pae HO, Kim EC, Chung HT (2008) Integrative survival response evoked by heme oxygenase-1 and heme metabolites. J Clin Biochem Nutr 42:197-203
23. Pae HO, Son Y, Kim NH, Jeong HJ, Chang KC, Chung HT (2010) Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide 23:251-257
24. Panickar KS, Anderson RA (2011) Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia. Int J Mol Sci 12:8181-8207
25. Piotrowska H, Kucinska M, Murias M (2012) Biological activity of piceatannol: leaving the shadow of resveratrol. Mutat Res 750:60-82
26. Raval AP, Dave KR, Pérez-Pinzón MA (2006) Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 26:1141-1147
27. Richard T, Pawlus AD, Iglésias ML, Pedrot E, Waffo-Teguo P, Mérillon JM, Monti JP (2011) Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci 1215:103-108
28. Robb EL, Stuart JA (2010) Trans-resveratrol as a neuroprotectant. Molecules 15:1196-1212
29. Roupe KA, Yáñez JA, Teng XW, Davies NM (2006) Pharmacokinetics of selected stilbenes. Rhapontigenin, piceatannol, and pinosylvin in rats. J Pharm Pharmacol 58:1443-1450
30. Sakata Y, Zhuang H, Kwansa H, Koehler RC, Doré S (2010) Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp Neurol 224:325-329
31. Sun AY, Wang Q, Simonyi A, Sun GY (2010) Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 41:375-383
32. Tan JW, Tham CL, Israf DA, Lee SH, Kim MK (2013) Neuroprotective effects of biochanin a against glutamate-induced cytotoxicity in PC12 cells via apoptosis inhibition. Neurochem Res 38:512-518
33. Wung BS, Hsu MC, Wu CC, Hsieh CW (2006) Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways. Pharmacol Res 53:113-122
34. Yang H, Sung SH, Kim J, Kim YC (2011) Neuroprotective diarylheptanoids from the leaves and twigs of Juglans sinensis against glutamate-induced toxicity in HT22 cells. Planta Med 77:841-845
35. Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB (2002) Human, rat, and mouse metabolism of resveratrol. Pharm Res 19:1907-1914